Technologies

USF researchers have developed novel materials and methods for the screening, diagnosis, and treatment of LGL leukemia and associated autoimmune disorders such as rheumatoid arthritis. A series of novel gene sequences in these disorders have been identified and can be used as molecular markers for screening and diagnostic measures. The same gene sequences may also be utilized as novel therapeutic targets for treatment. A biological sample is taken for the screening and treatment process and can be obtained from various fluids including the peripheral blood, urine, or saliva.

Researchers at the University of South Florida have developed a novel method which utilizes gene sequences as markers to screen, detect, diagnose, and treat large granular lymphocyte (LGL) leukemia.